The United States Supreme Court has rejected Pfizer’s appeal of a $2.7 million verdict resulting from its Prempro hormone-replacement treatment being linked to breast cancer. Pfizer requested the appeal after a lower court upheld the compensatory award of $2.7 million..

Follow this link:
Appeal Rejected in Hormone Replacement Drug Case

Legal News banks, class action lawsuit, conspiracy, crime in the news, donna scroggin, faisal shahzad, legal news, merchants, new york, prempro, vicarious liability, wrongful death, wyeth